Collectively, these studies appear to indicate that gut microbiota can be used as a promising therapeutic target to limit the development of different metabolic and cardiovascular risk factors observed in BD patients
Minamimoto R, Hotta M, Ishikane M, Inagaki T
" " " 'H.O.P'( ) , "
Res 50 , 840852 (2020)
It preserves cellular damage recovery, boosts collagen production, and maintains telomere length
At 52 weeks, a reduction in circulating volume and blood pressure is observed, associated with decreased levels of adipokines and aldosterone, alongside reduced albuminuria and increased glomerular filtration rate compared with placebo, suggesting an additional renal benefit.47 GIP antagonist - GLP-1 agonist: MariTida This drug (Maridebart-cafraglutide or AMG 133), which is a conjugate of a monoclonal antibody to the GIP receptor and two GLP-1 receptor agonist molecules, is effective in reducing body weight in obese mice and cynomolgus monkeys